UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

The Lancet (British edition), 2021-06, Vol.397 (10290), p.2182-2193

2021

Volltextzugriff (PDF)

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

The lancet oncology, 2009-04, Vol.10 (4), p.327-340

2009

Volltextzugriff (PDF)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States

PloS one, 2021-06, Vol.16 (6), p.e0243676-e0243676

2021

Volltextzugriff (PDF)

Ovarian Cancer Screening: Development of the Risk of Ovarian Cancer Algorithm (ROCA) and ROCA Screening Trials

International journal of gynecological cancer, 2012-05, Vol.22 Suppl 1 (S1), p.S24-S26

Skates, Steven J

2012

Volltextzugriff (PDF)

EPIC Early Detection of Ovarian Cancer

Clinical cancer research, 2016-09, Vol.22 (18), p.4542-4544

Skates, Steven J

2016

Volltextzugriff (PDF)

Biomarkers and Strategies for Early Detection of Ovarian Cancer

Cancer epidemiology, biomarkers & prevention, 2020-12, Vol.29 (12), p.2504-2512

2020

Volltextzugriff (PDF)

Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma

Molecular & cellular proteomics, 2012-06, Vol.11 (6), p.M111.013854-M111.013854, Article M111.013854

2012

Volltextzugriff (PDF)

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies

Cancer epidemiology, biomarkers & prevention, 2022-06, Vol.31 (6), p.1139-1145

2022

Volltextzugriff (PDF)

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

American journal of obstetrics and gynecology, 2010-09, Vol.203 (3), p.228.e1-228.e6

2010

Volltextzugriff (PDF)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Thorax, 2014-10, Vol.69 (10), p.895-902

2014

Volltextzugriff (PDF)

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1411-1420

2017

Volltextzugriff (PDF)

Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass

Obstetrics and gynecology (New York. 1953), 2011-08, Vol.118 (2), p.280-288

2011

Volltextzugriff (PDF)

A New Era of Protein-Based Assays for Cancer Early Detection

Journal of thoracic oncology, 2021-02, Vol.16 (2), p.191-193

2021

Volltextzugriff (PDF)

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199

Journal of clinical oncology, 2014-10, Vol.32 (29), p.3275-3283

2014

Volltextzugriff (PDF)

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Gynecologic oncology, 2009-01, Vol.112 (1), p.40-46

2009

Volltextzugriff (PDF)

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer

Clinical cancer research, 2017-10, Vol.23 (19), p.5912-5922

2017

Volltextzugriff (PDF)

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

Clinical cancer research, 2017-07, Vol.23 (14), p.3628-3637

2017

Volltextzugriff (PDF)

Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule

Journal of clinical oncology, 2013-01, Vol.31 (1), p.49-57

2013

Volltextzugriff (PDF)

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma

Scientific reports, 2023-01, Vol.13 (1), p.1537-1537, Article 1537

2023

Volltextzugriff (PDF)

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

Journal of clinical oncology, 2015-06, Vol.33 (18), p.2062-2071

2015

Volltextzugriff (PDF)

Human epididymis protein 4 antigen‐autoantibody complexes complement cancer antigen 125 for detecting early‐stage ovarian cancer

Cancer, 2020-02, Vol.126 (4), p.725-736

2020

Volltextzugriff (PDF)

Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial

The lancet oncology, 2023-09, Vol.24 (9), p.1018-1028

2023

Volltextzugriff (PDF)

Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Gynecologic oncology, 2023-12, Vol.179, p.123-130

2023

Volltextzugriff (PDF)

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

Radiology, 2007-08, Vol.244 (2), p.381

2007

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(164)

Publikationsform

Sprache

Englisch
(185)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Proteogenomics connects somatic mutations to signalling in breast cancer

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States

Ovarian Cancer Screening: Development of the Risk of Ovarian Cancer Algorithm (ROCA) and ROCA Screening Trials

EPIC Early Detection of Ovarian Cancer

Biomarkers and Strategies for Early Detection of Ovarian Cancer

Interlaboratory Evaluation of Automated, Multiplexed Peptide Immunoaffinity Enrichment Coupled to Multiple Reaction Monitoring Mass Spectrometry for Quantifying Proteins in Plasma

Multicancer Early Detection Technologies: A Review Informed by Past Cancer Screening Studies

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass

A New Era of Protein-Based Assays for Cancer Early Detection

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials

Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening

Human epididymis protein 4 antigen‐autoantibody complexes complement cancer antigen 125 for detecting early‐stage ovarian cancer

Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial

Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study

Suchergebnisse filtern